Rheumatoid arthritis | Nature Reviews Disease Primers
RESEARCH HIGHLIGHTS Serum monomeric prolactin levels predict SLE disease severity A new model for rheumatoid arthritis etiology
Cytokines in the pathogenesis of rheumatoid arthritis | Nature Reviews Immunology
Signaling pathways in rheumatoid arthritis: implications for targeted therapy | Signal Transduction and Targeted Therapy
Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways | Nature Reviews Rheumatology
Volume 2 Issue 10, October 2006
Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis | Nature Reviews Rheumatology
Représentation multi-échelle de l'organisation moléculaire au sein du... | Download Scientific Diagram
Biologics registers in RA: methodological aspects, current role and future applications | Nature Reviews Rheumatology
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting | Nature Reviews Immunology
The role of neutrophils in rheumatic disease-associated vascular inflammation | Nature Reviews Rheumatology
Nature Clinical Practice Rheumatology Impact Factor:... | Exaly
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE | Nature Reviews Rheumatology
Volume 3 Issue 2, February 2007
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Transforming clinical trials in rheumatology: towards patient-centric precision medicine | Nature Reviews Rheumatology
Nature Clinical Practice Rheumatology Impact Factor:... | Exaly
RESEARCH HIGHLIGHTS COX-2 inhibitor use in the Women's Health Initiative trials: re-analysis of the data The use of antimalari
RESEARCH HIGHLIGHTS Pegsunercept is a safe and efficacious treatment for rheumatoid arthritis More support for MRI-based screeni
Medscape | Nat Clin Pract Rheumatol - Publication Information
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
RESEARCH HIGHLIGHTS Infliximab increases bone mineral density in patients with rheumatoid arthritis PEG-uricase is effective aga
The complement system as a potential therapeutic target in rheumatic disease | Nature Reviews Rheumatology
Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis | Nature Reviews Rheumatology
